92cf03cf5198a43dc1ec942ad3b71735 pmc_26097039.pdf 1cab75697bd4b0ee1cca5f926d6339ae9e69db14 pmc_26097039.pdf 4676eb75984b980897ae7008ef7ec7a670e05a2fb69db63086af0ca2b754b209 pmc_26097039.pdf Title: Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial Subject: Creator: Arbortext Advanced Print Publisher 9.0.114/W Producer: Adobe LiveCycle PDFG ES CreationDate: Fri Nov 20 19:52:36 2015 CET ModDate: Fri Nov 20 19:52:53 2015 CET Tagged: no UserProperties: no Suspects: no Form: none JavaScript: no Pages: 11 Encrypted: no Page size: 629.972 x 809.972 pts Page rot: 0 File size: 261596 bytes Optimized: yes PDF version: 1.5 name type encoding emb sub uni object ID ------------------------------------ ----------------- ---------------- --- --- --- --------- ACPDKM+AdvPSMEL Type 1C Custom yes yes no 124 0 ACPDLN+AdvP80516 Type 1C Custom yes yes yes 103 0 ACPEAM+AdvPSMEL-B Type 1C MacRoman yes yes no 128 0 ACPEAN+AdvP4C4E59 Type 1C Custom yes yes no 108 0 ACPEAO+AdvPSMEL-BI Type 1C WinAnsi yes yes no 131 0 ACPEBP+AdvPS_SSYB Type 1C Custom yes yes yes 112 0 ACPEGO+AdvP7DA6 Type 1C Custom yes yes yes 66 0 ACPEGP+AdvP80675 Type 1C Custom yes yes yes 71 0 ACPEIP+AdvP4C4E74 Type 1C Custom yes yes no 3 0 ACPEKP+AdvPSMEL-I Type 1C WinAnsi yes yes no 63 0 ACPFDN+Helvetica Type 1C WinAnsi yes yes no 9 0 ACPFEN+Helvetica-Bold Type 1C WinAnsi yes yes no 76 0 ACPGEI+Helvetica Type 1C WinAnsi yes yes no 27 0 ACPGFJ+Symbol Type 1C Custom yes yes yes 80 0 ACPHEE+Helvetica Type 1C WinAnsi yes yes no 42 0 ACPHFF+TimesNewRomanPS-BoldMT Type 1C WinAnsi yes yes no 45 0 Jhove (Rel. 1.6, 2011-01-04) Date: 2019-03-20 04:54:20 CET RepresentationInformation: pmc_26097039.pdf ReportingModule: PDF-hul, Rel. 1.8 (2009-05-22) LastModified: 2018-01-31 06:08:16 CET Size: 261596 Format: PDF Version: 1.5 Status: Well-Formed and valid SignatureMatches: PDF-hul MIMEtype: application/pdf Profile: Linearized PDF PDFMetadata: Objects: 135 FreeObjects: 1 IncrementalUpdates: 1 DocumentCatalog: PageLayout: SinglePage PageMode: UseNone Info: Title: Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial Subject: Creator: Arbortext Advanced Print Publisher 9.0.114/W Producer: Adobe LiveCycle PDFG ES CreationDate: Fri Nov 20 20:22:36 CET 2015 ModDate: Fri Nov 20 20:22:53 CET 2015 ID: 0x144660e9d518787706721b6d1d7f2a3e00, 0x09cc4242e50a25e353527439867fffff Filters: FilterPipeline: FlateDecode Fonts: Type1: Font: BaseFont: ACPEAM+AdvPSMEL-B FontSubset: true FirstChar: 36 LastChar: 245 FontDescriptor: FontName: ACPEAM+AdvPSMEL-B Flags: Serif, Nonsymbolic FontBBox: -125, -250, 1000, 760 FontFile3: true Encoding: MacRomanEncoding Font: BaseFont: ACPEGO+AdvP7DA6 FontSubset: true FirstChar: 35 LastChar: 36 FontDescriptor: FontName: ACPEGO+AdvP7DA6 Flags: Serif, Symbolic FontBBox: -20, -208, 1000, 770 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: ACPEAO+AdvPSMEL-BI FontSubset: true FirstChar: 46 LastChar: 118 FontDescriptor: FontName: ACPEAO+AdvPSMEL-BI Flags: Serif, Nonsymbolic FontBBox: -156, -250, 1083, 739 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: ACPEIP+AdvP4C4E74 FontSubset: true FirstChar: 2 LastChar: 2 FontDescriptor: FontName: ACPEIP+AdvP4C4E74 Flags: Symbolic FontBBox: -20, -958, 1114, 770 FontFile3: true EncodingDictionary: Differences: true Font: BaseFont: ACPDLN+AdvP80516 FontSubset: true FirstChar: 86 LastChar: 86 FontDescriptor: FontName: ACPDLN+AdvP80516 Flags: Symbolic FontBBox: 0, -218, 989, 760 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: ACPEGP+AdvP80675 FontSubset: true FirstChar: 44 LastChar: 109 FontDescriptor: FontName: ACPEGP+AdvP80675 Flags: Symbolic FontBBox: -20, -229, 1010, 812 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: ACPFDN+Helvetica FontSubset: true FirstChar: 32 LastChar: 129 FontDescriptor: FontName: ACPFDN+Helvetica Flags: Nonsymbolic FontBBox: -166, -225, 1000, 931 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: ACPHEE+Helvetica FontSubset: true FirstChar: 32 LastChar: 117 FontDescriptor: FontName: ACPHEE+Helvetica Flags: Nonsymbolic FontBBox: -166, -225, 1000, 931 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: ACPEAN+AdvP4C4E59 FontSubset: true FirstChar: 2 LastChar: 3 FontDescriptor: FontName: ACPEAN+AdvP4C4E59 Flags: Serif, Symbolic FontBBox: -31, -250, 1000, 750 FontFile3: true EncodingDictionary: Differences: true Font: BaseFont: ACPFEN+Helvetica-Bold FontSubset: true FirstChar: 32 LastChar: 116 FontDescriptor: FontName: ACPFEN+Helvetica-Bold Flags: Nonsymbolic, ForceBold FontBBox: -170, -228, 1003, 962 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: ACPHFF+TimesNewRomanPS-BoldMT FontSubset: true FirstChar: 65 LastChar: 66 FontDescriptor: FontName: ACPHFF+TimesNewRomanPS-BoldMT Flags: Nonsymbolic FontBBox: -558, -307, 2000, 1026 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: ACPEBP+AdvPS_SSYB FontSubset: true FirstChar: 60 LastChar: 130 FontDescriptor: FontName: ACPEBP+AdvPS_SSYB Flags: Serif, Symbolic FontBBox: -197, -270, 1135, 989 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: ACPGFJ+Symbol FontSubset: true FirstChar: 2 LastChar: 32 FontDescriptor: FontName: ACPGFJ+Symbol Flags: Symbolic FontBBox: -180, -293, 1090, 1010 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: ACPGEI+Helvetica FontSubset: true FirstChar: 32 LastChar: 118 FontDescriptor: FontName: ACPGEI+Helvetica Flags: Nonsymbolic FontBBox: -166, -225, 1000, 931 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: ACPDKM+AdvPSMEL FontSubset: true FirstChar: 30 LastChar: 167 FontDescriptor: FontName: ACPDKM+AdvPSMEL Flags: Serif, Nonsymbolic FontBBox: -125, -250, 1000, 739 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true Font: BaseFont: ACPEKP+AdvPSMEL-I FontSubset: true FirstChar: 38 LastChar: 146 FontDescriptor: FontName: ACPEKP+AdvPSMEL-I Flags: Serif, Nonsymbolic FontBBox: -104, -260, 1072, 739 FontFile3: true Encoding: WinAnsiEncoding XMP: application/pdf Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial Adobe LiveCycle PDFG ES 10.1002/acr.22645 10.1002/(ISSN)2151-4658 3 2015-11-21T00:22:36+05:30 Arbortext Advanced Print Publisher 9.0.114/W 2015-11-21T00:22:53+05:30 2015-11-21T00:22:53+05:30 uuid:ec70c10d-ddb0-2976-5177-1873fea8f6a6 uuid:8e91f1f8-5087-2e34-5b35-1873fea8f6a6 Pages: Page: Label: 1739 Sequence: 1 Annotations: Annotation: Subtype: Link Rect: 291, 702, 369, 711 Annotation: Subtype: Link Rect: 62, 693, 221, 702 Page: Label: 1740 Sequence: 2 Page: Label: 1741 Sequence: 3 Page: Label: 1742 Sequence: 4 Page: Label: 1743 Sequence: 5 Page: Label: 1744 Sequence: 6 Annotations: Annotation: Subtype: Link Rect: 224, 281, 302, 290 Annotation: Subtype: Link Rect: 62, 270, 229, 279 Annotation: Subtype: Link Rect: 442, 136, 566, 145 Annotation: Subtype: Link Rect: 327, 124, 449, 133 Page: Label: 1745 Sequence: 7 Annotations: Annotation: Subtype: Link Rect: 277, 338, 302, 347 Annotation: Subtype: Link Rect: 62, 326, 284, 335 Annotation: Subtype: Link Rect: 373, 552, 566, 561 Annotation: Subtype: Link Rect: 327, 540, 386, 549 Page: Label: 1746 Sequence: 8 Page: Label: 1747 Sequence: 9 Annotations: Annotation: Subtype: Link Rect: 156, 197, 302, 206 Annotation: Subtype: Link Rect: 62, 186, 173, 195 Page: Label: 1748 Sequence: 10 Page: Label: 1749 Sequence: 11 Checksum: 528283e2 Type: CRC32 Checksum: 92cf03cf5198a43dc1ec942ad3b71735 Type: MD5 Checksum: 1cab75697bd4b0ee1cca5f926d6339ae9e69db14 Type: SHA-1